MIAMI LAKES, Fla., March 1, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce that CEO Brian Tuffin and Daymond John, CEO of Shark Branding, LLC and Shark Branding Corp. are scheduled to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox" today, March 1st, 2013.
"Taking Stock", hosted by Bloomberg Television anchor Pimm Fox, offers insight into company news, long-term strategy, trading tactics, market techniques, stocks, bonds, commodities and currencies and is broadcast weekdays at 5:00 pm EST.
A replay of the interview will be archived and available within the Investor Relations section of the Fuse Science, Inc. corporate web site: http://ir.stockpr.com/fusescience/overview shortly after the broadcast.
About Shark Branding Corp.
Shark Branding's team of expert communicators, strategic analysts, and creative heavyweights excels in transforming businesses into iconic brands. At the helm is business and branding expert Daymond John, CEO and Founder of FUBU, a $6 billion global fashion game-changer. Daymond's entrepreneurialism and trend-moving influence are key to the company's cultivation of great brands. Putting products in the hands of influencers and trendsetters is Shark Branding's core practice. Shark Branding clients benefit from a 360 degree approach to the growth of a healthy, successful brand with services ranging from brand strategy, design, and licensing; event development; celebrity affiliation and media; digital marketing; and the fundamentals of business leadership. For more information, visit: www.sharkbranding.com
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement
Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science, Inc.